0591-2312

Generic: alvimopan

Labeler: actavis pharma, inc.
NDC Directory DRUG FOR FURTHER PROCESSING DRUG FOR FURTHER PROCESSING Active

Drug Facts

Product Profile

Brand Name
Generic Name alvimopan
Labeler actavis pharma, inc.
Dosage Form CAPSULE
Active Ingredients

alvimopan 12 mg/1

Identifiers & Regulatory

Product NDC 0591-2312
Product ID 0591-2312_60f84bf9-5853-4ab1-842f-118f1e146f8a
Product Type DRUG FOR FURTHER PROCESSING
Marketing Category DRUG FOR FURTHER PROCESSING
Listing Expiration 2026-12-31
Marketing Start 2020-10-13

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05912312
Hyphenated Format 0591-2312

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name alvimopan (source: label)
Generic Name alvimopan (source: ndc)
Application Number ANDA208295 (source: label)
Routes
oral
source: label

Resolved Composition

Strengths
  • 12 mg/1
source: ndc
Packaging
  • 20000 CAPSULE in 1 BOX (0591-2312-00)
source: ndc

Packages (1)

0591-2312-00 20000 CAPSULE in 1 BOX (0591-2312-00)

Ingredients (1)

alvimopan (12 mg/1)

Linked Drug Pages (1)

Alvimopan ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "60f84bf9-5853-4ab1-842f-118f1e146f8a", "openfda": {}, "finished": false, "packaging": [{"description": "20000 CAPSULE in 1 BOX (0591-2312-00)", "package_ndc": "0591-2312-00", "marketing_start_date": "13-OCT-20"}], "product_id": "0591-2312_60f84bf9-5853-4ab1-842f-118f1e146f8a", "dosage_form": "CAPSULE", "product_ndc": "0591-2312", "generic_name": "Alvimopan", "labeler_name": "Actavis Pharma, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "ALVIMOPAN", "strength": "12 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20201013", "listing_expiration_date": "20261231"}